Jennifer B. Damico - 27 Feb 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
SVP & Controller
Signature
Susan E. Grant, by power of atty., for Jennifer B. Damico
Issuer symbol
PFE
Transactions as of
27 Feb 2024
Net transactions value
$0
Form type
4
Filing time
28 Feb 2024, 16:58:42 UTC
Previous filing
27 Feb 2024
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Award $0 +5,113 +61% $0.000000 13,495 27 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Award $0 +19,697 $0.000000 19,697 27 Feb 2024 Common Stock 19,697 $26.89 Direct F2
transaction PFE Stock Appreciation Rights Award $0 +17,404 $0.000000 17,404 27 Feb 2024 Common Stock 17,404 $26.89 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.